Synergy of Irofulven in combination with various anti-metabolites, enzyme inhibitors, and miscellaneous agents in MV522 lung carcinoma cells: marked interaction with gemcitabine and 5-fluorouracil

Trevor McMorris; Rafael Rojas; Leita Estes; Pharnuk Suthipinijtham
October 2008
Investigational New Drugs;Oct2008, Vol. 26 Issue 5, p407
Academic Journal
Summary  The novel agent Irofulven (HMAF, NSC 683863) has demonstrated significant antitumor activity against solid tumors in various xenograft models and human clinical trials. The antitumor potential of combining irofulven with 72 different anti-metabolite, enzyme inhibiting, and miscellaneous agents was investigated in this study. The human lung carcinoma MV522 cell line and its corresponding xenograft model were used to evaluate the activity of irofulven in combination with these different agents. Irofulven in combination with select anti-metabolites, notably cytidine or adenine-derived agents, displayed strong synergistic activity in both in vitro and in vivo studies. Agents demonstrating strong synergistic interaction with irofulven included gemcitabine, cyclocytidine, cytarabine, fludarabine phosphate, cladribine, and 5-fluorouracil. Other anti-metabolites, enzyme inhibitors, and a variety of miscellaneous agents failed to interact beneficially when administered in combination with irofulven. The therapeutic activity of irofulven is enhanced considerably when irofulven is combined with select anti-metabolite agents, and further clinical evaluation of these combinations is warranted. The synergistic interaction with these combinations may stem from a variety of actions including inhibition of the nucleotide excision repair (NER) pathway, topoisomerase I activity, and caspase-dependent and independent induction of apoptosis.


Related Articles

  • Anti-Tumor Effects of Atractylenolide I Isolated from Atractylodes macrocephala in Human Lung Carcinoma Cell Lines. Huanyi Liu; Yajie Zhu; Tao Zhang; Zhenguo Zhao; Yu Zhao; Peng Cheng; Hua Li; Hui Gao; Xiaomei Su // Molecules;Nov2013, Vol. 18 Issue 11, p13357 

    Atractylenolide I (ATL-1) is the major sesquiterpenoid of Atractylodes macrocephala. This study was designed to investigate whether ATL-1 induced apoptosis in A549 and HCC827 cells in vitro and in vivo. In our results, ATL-1 significantly decreased the percentage of in vitro viability, in a...

  • Methyl protodioscin induces G2/M cell cycle arrest and apoptosis in A549 human lung cancer cells. Yang Bai; Xiao-Yuan Qu; Jun-Qiang Yin; Liangcai Wu; Hong Jiang; Han-Wu Long; Qiang Jia // Pharmacognosy Magazine;Jul-Sep2014, Vol. 10 Issue 39, p318 

    Background: Methyl protodioscin (MPD) is a furostanol bisglycoside with antitumor properties. It has been shown to reduce proliferation, cause cell cycle arrest. Objective: The present study elucidates the mechanism underlying MPD's apoptotic effects, using the A549 human lung cancer cell line....

  • Combining IGFBP-3 and a Farnesyltransferase Inhibitor.  // JNCI: Journal of the National Cancer Institute;10/20/2004, Vol. 96 Issue 20, p1487 

    Reports on the role of overexpression of insulin-like growth factor binding protein 3 (IGFBP-3) in inducing apoptosis in non-small-cell lung cancer (NSCLC) cells. Capability of cells to become resistant to IGFBP-3; Evaluation of the therapeutic potential of combining IGFBP-3 with SCG66336, a...

  • Comparison of the pharmacological profile of an olivacine derivative and a potential prodrug. Kraus-Berthier, Laurence; Guilbaud, Nicolas; Léonce, Stéphane; Parker, Tracy; Genissel, Patrick; Guillonneau, Claude; Goldstein, Solo; Atassi, Ghanem; Pierré, Alain // Cancer Chemotherapy & Pharmacology;Aug2002, Vol. 50 Issue 2, p95 

    Background. The new olivacine derivative S 16020-2 (NSC-659687) has entered clinical trials on the basis of a marked antitumor activity in experimental models. Amongst the analogues which were synthesized to improve both therapeutic index and antitumor activity, the most active ones were those...

  • Irinotecan–cisplatin interactions assessed in cell-based screening assays: cytotoxicity, drug accumulation and DNA adduct formation in an NSCLC cell line. Zastre, Jason; Anantha, Malathi; Ramsay, Euan; Bally, Marcel // Cancer Chemotherapy & Pharmacology;Jun2007, Vol. 60 Issue 1, p91 

    The use of in vitro drug cytotoxicity assays for the assessment of drug–drug interactions that lead to synergy may not take into account the many cellular determinants responsible for combination effects. Administration of the anticancer drug CPT-11, for example, is associated with rapid...

  • Aryl and Acyclic Unsaturated Derivatives of Thioguanine and 6-Mercaptopurine: Synthesis and Cytotoxic Activity. Banh, Tien N.; Kode, Nageswara R.; Phadtare, Shashikant // Letters in Drug Design & Discovery;Oct2011, Vol. 8 Issue 8, p709 

    A series of aryl and acyclic unsaturated chloromethyl derivatives of thioguanine and 6-mercaptopurine 1-20 were synthesized. These compounds were evaluated for cytotoxic activity against NCI-60 DTP human tumor cell line screen at 10 µMolar concentration. Compound 1 exhibited potent cytotoxic...

  • Antimetastatic Effects of Phyllanthus on Human Lung (A549) and Breast (MCF-7) Cancer Cell Lines. Lee, Sau Har; Jaganath, Indu Bala; Seok Mui Wang; Sekaran, Shamala Devi // PLoS ONE;2011, Vol. 6 Issue 6, p1 

    Background: Current chemotherapeutic drugs kill cancer cells mainly by inducing apoptosis. However, they become ineffective once cancer cell has the ability to metastasize, hence the poor prognosis and high mortality rate. Therefore, the purpose of this study was to evaluate the antimetastatic...

  • 3-Hydroxyflavone inhibits endogenous Aurora B and induces growth inhibition of cancer cell line. Qingyu Lang; Haoxing Zhang; Jie Li; Fang Xie; Yifeng Zhang; Bo Wan; Long Yu // Molecular Biology Reports;Mar2010, Vol. 37 Issue 3, p1577 

    Abstract  The Aurora kinases play a critical role in mitosis and have been suggested as promising targets for cancer therapy due to their frequent overexpression in a variety of tumors. Compared with established inhibitors of cell division such as the anti-tubulins, novel agents target...

  • Effect of arsenic trioxide (ATO) on human lung carcinoma PG cell line: ATO induced apoptosis of PG cells and decreased expression of Bcl-2, Pgp. Bo Han; Gengyin Zhou; Qinghui Zhang; Jing Zhang; Xiaojuan Wang; Weihua Tang; Kennichi Kakudo // Journal of Experimental Therapeutics & Oncology;2004, Vol. 4 Issue 4, p335 

    Arsenic trioxide (ATO) has been established to be an effective agent for treating newly diagnosed and relapsed acute promyelocytic leukemia (APL) patients. Laboratory data suggest that ATO induces apoptosis of hematopoietic or several solid tumor cells. However, to date, its effect on lung...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics